Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
4(33%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
9
75%
Ph phase_4
1
8%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(7)
Other(1)

Detailed Status

Completed7
Recruiting3
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 41 (8.3%)
N/A9 (75.0%)

Trials by Status

recruiting325%
unknown18%
active_not_recruiting18%
completed758%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12